Peripheral zone prostate cancer: accuracy of different interpretative approaches with MR and MR spectroscopic imaging.
about
Trends in targeted prostate brachytherapy: from multiparametric MRI to nanomolecular radiosensitizersRole of multiparametric magnetic resonance imaging in early detection of prostate cancerA feasibility study of novel ultrasonic tissue characterization for prostate-cancer diagnosis: 2D spectrum analysis of in vivo data with histology as gold standard.Combined magnetic resonance imaging and magnetic resonance spectroscopy imaging in the diagnosis of prostate cancer: a systematic review and meta-analysis.Detection of fully refocused polyamine spins in prostate cancer at 7 T.Prostate cancer: value of multiparametric MR imaging at 3 T for detection--histopathologic correlationExploration of analysis methods for diagnostic imaging tests: problems with ROC AUC and confidence scores in CT colonography.Is apparent diffusion coefficient associated with clinical risk scores for prostate cancers that are visible on 3-T MR images?Usefulness of a combined approach of t1-weighted, t2-weighted, dynamic contrast-enhanced, and diffusion-weighted imaging in prostate cancer.Prostate cancer magnetic resonance imaging (MRI): multidisciplinary standpoint.Multi-kernel graph embedding for detection, Gleason grading of prostate cancer via MRI/MRSRole of magnetic resonance imaging and magnetic resonance spectroscopic imaging before and after radiotherapy for prostate cancerAdvances in prostate cancer imaging techniques and strategies.Prostate cancer: sextant localization at MR imaging and MR spectroscopic imaging before prostatectomy--results of ACRIN prospective multi-institutional clinicopathologic study.The role of magnetic resonance imaging (MRI) in prostate cancer imaging and staging at 1.5 and 3 Tesla: the Beth Israel Deaconess Medical Center (BIDMC) approachMagnetic resonance imaging in diagnosis, staging and radiotherapy planning for prostate cancer.Imaging in prostate cancer.A decade in prostate cancer: from NMR to metabolomics.Magnetic resonance spectroscopy: a promising tool for the diagnostics of human prostate cancer?Integrating multiparametric prostate MRI into clinical practice.Scoring systems used for the interpretation and reporting of multiparametric MRI for prostate cancer detection, localization, and characterization: could standardization lead to improved utilization of imaging within the diagnostic pathway?MRI in prostate cancer.Preoperative mp-MRI of the prostate provides little information about staging of prostate carcinoma in daily clinical practice.Effect of Prostate Biopsy Hemorrhage on MRDW and MRS Imaging.Multiparametric MRI for prostate cancer detection: performance in patients with prostate-specific antigen values between 2.5 and 10 ng/mL.Endorectal MRI and MR spectroscopic imaging of prostate cancer: developing selection criteria for MR-guided focal therapy.Clinically low-risk prostate cancer: evaluation with transrectal doppler ultrasound and functional magnetic resonance imaging.Fast T2*-weighted MRI of the prostate at 3 Tesla.MR spectroscopic imaging and diffusion-weighted imaging of prostate cancer with Gleason scores.Automatic conformal prescription of very selective saturation bands for in vivo 1H-MRSI of the prostate.Reproducibility of 3D 1H MR spectroscopic imaging of the prostate at 1.5T.
P2860
Q26738622-A6440D05-BBA9-4302-AB5B-D47B72226626Q26768765-63EC02AE-51ED-41F3-9031-078195A8FEB8Q30480275-8BFBDEEA-D315-4E63-9417-482AE091FF05Q33379495-D9431CFB-8017-4758-A99F-CBA59263B140Q33711402-F2AED1AF-6254-4A36-9E2B-8F0620E85441Q33746637-A1594679-43C7-4D5A-A787-8AB08BAB1111Q34420751-861968E0-B736-4863-A8FC-78D253E1A255Q34534796-DD6380D9-86B1-4878-A71C-75FF045B6CD0Q36492465-58E664DC-656E-416F-A325-12888C678CA6Q36795496-229E026C-47A1-4CA8-BF12-79ADA1E8C977Q37003074-6049F650-234A-4CB3-8CCF-396C8ABD80EEQ37119015-84DB0AAF-CD61-49FD-9B4F-574587F35693Q37127345-9214413F-E6EA-43FE-9E57-E4B1C8B56E11Q37145968-9D7BE504-FB34-4B27-B6B6-650436F0EA70Q37337735-81180826-4863-40B7-8D06-DD86DE9E0C81Q37832487-520CDAE5-1EA2-4D16-8364-2FB462B7B463Q37875083-1D216671-D632-417D-91FE-7E9D45889FDBQ37876681-384F4591-BB8D-456A-88F8-AE6354B932CCQ37935194-92D0AF66-37C5-427E-9E31-BE7E57F07EF7Q37970305-8CA6DA99-D8C1-4BAF-B38D-127AE3CF1619Q38008282-4282BF47-26B1-4ECB-8E06-148D97AABC29Q38201469-ADED17D3-2705-44FE-8506-1782BA3DC757Q38272447-342ECEBD-EE50-482D-BA97-586509E70253Q38468586-37504244-EEE1-4106-BAE2-EA83C2A5FCDCQ40206375-B525A2DD-C0AE-4AB6-8448-558BC499CEF0Q41769436-52AEB1B8-0F3E-441B-A72F-68355AB3F4D4Q41778954-C29870EC-6B24-4DF0-98EF-B414BF787F42Q42051192-42A1A2FD-A4FC-42C3-B4D4-5070AE418B23Q44335988-3DC3F368-3686-4C70-B48B-9E2F33912B02Q45309733-F80A6B20-7A7C-4C8F-B706-87FF4F2F365DQ53089466-84BB3B1A-F196-4CD9-8602-E965842A9CFA
P2860
Peripheral zone prostate cancer: accuracy of different interpretative approaches with MR and MR spectroscopic imaging.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Peripheral zone prostate cance ...... and MR spectroscopic imaging.
@en
Peripheral zone prostate cance ...... and MR spectroscopic imaging.
@nl
type
label
Peripheral zone prostate cance ...... and MR spectroscopic imaging.
@en
Peripheral zone prostate cance ...... and MR spectroscopic imaging.
@nl
prefLabel
Peripheral zone prostate cance ...... and MR spectroscopic imaging.
@en
Peripheral zone prostate cance ...... and MR spectroscopic imaging.
@nl
P2093
P1433
P1476
Peripheral zone prostate cance ...... and MR spectroscopic imaging.
@en
P2093
Aliya Qayyum
Antonio C Westphalen
Benjamin M Yeh
Fergus V Coakley
Jeffry P Simko
John Kurhanewicz
Mark Swanson
Peter R Carroll
Shoujun Zhao
P304
P356
10.1148/RADIOL.2453062042
P407
P577
2007-11-16T00:00:00Z